Treatment outcomes for multidrug- and rifampicin-resistant tuberculosis in Central and West Africa: a systematic review and meta-analysis
25 August 2022
We aimed to investigate published data on treatment outcomes of MDR/RR-TB in Central and West Africa as these, to our knowledge, are sparsely available.
The use of shorter treatment regimens and the standardized treatment conditions including DOT in these studies could have contributed to a high treatment success. Yet, the available literature was not fully representative of the regions, possibly highlighting the sparse resources in many of these countries.
Further reading: International Journal of Infectious Diseases
Author(s): Asbjørn Langeland Toft et al
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
LifeArc |
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!